Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression (Q28299091)

1

0 references

K J Jeong

2

0 references

N Panupinthu

3

0 references

S Yu

4

0 references

J Lee

5

0 references

J W Han

6

0 references

J M Kim

7

0 references

J-S Lee

8

0 references

J Kang

9

0 references

C G Park

10

0 references

H Y Lee

The emerging role of lysophosphatidic acid in cancer

12

0 references

language of work or name

English

0 references

publication date

17 March 2011

0 references

published in

Oncogene

0 references

volume

30

0 references

page(s)

1351-9

0 references

issue

11

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.517

Agonist-induced endocytosis of lysophosphatidic acid-coupled LPA1/EDG-2 receptors via a dynamin2- and Rab5-dependent pathway

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.517

The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.517

Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.517

Prevention of TNF-induced necrotic cell death by rottlerin through a Nox1 NADPH oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.517

Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.517

Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.517

Development of matrix metalloproteinase inhibitors in cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.517

Roles of ERK and p38 mitogen-activated protein kinases in phorbol ester-induced NF-kappaB activation and COX-2 expression in human breast epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.517

Activation of hypoxia-inducible factor-1alpha is necessary for lysophosphatidic acid-induced vascular endothelial growth factor expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.517

A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.517

FGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.517

Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.517

Sharpening the edges of understanding the structure/function of the LPA1 receptor: expression in cancer and mechanisms of regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.517

Lysophosphatidic acid (LPA) and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.517

Estimating the world cancer burden: Globocan 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.517

Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.517

Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.517

Autotaxin expression and its connection with the TNF-alpha-NF-kappaB axis in human hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.517

Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.517

Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.517

Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.517

A role for matrix metalloproteinases and tumor host interaction in hepatocellular carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.517

A novel laminin-induced LPA autocrine loop in the migration of ovarian cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.517

Novel recurrent genetic imbalances in human hepatocellular carcinoma cell lines identified by comparative genomic hybridization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.517

31 March 2020

Identifiers

DOI

10.1038/ONC.2010.517

1 reference

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

1290405

1026583812

0 references

1290405

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference